Anixa Biosciences Inc (NASDAQ:ANIX)
| 3.27 Delayed Data As of Sep 29 |  +0.06 / +1.87%Today’s Change | 2.90 Today|||52-Week Range 6.45 | -23.06% Year-to-Date |
Latest ANIX News | Press Releases
| ANIXA BIOSCIENCES INC (ANIX) Upgraded to Buy: What Does It Mean for the Stock? Sep 21 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 3.21 |
| Today’s open | 3.22 |
| Day’s range | 3.22 - 3.27 |
| Volume | 606 |
| Average volume (3 months) | 70,601 |
| Market cap | $111.2M |
Data as of 3:59pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | +1.26% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.81 |
Competitors
Data as of 4:00pm ET, 09/29/2023
Financials
| Last reporting date | September 29, 2023 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$13.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Jose, California |
Forecasts
